Foot ulcers are a common and devastating complication of diabetes. Many patients with diabetic foot ulcers experience significant disability and ultimately require amputation. Despite attentive management with multiple modalities including surgical debridement, relief of pressure, and other standard measures, many diabetic foot ulcers persist as chronic, non-healing wounds. Hyperbaric oxygen therapy is an effective adjunct to standard modalities for the treatment of diabetic foot ulcers. Hyperbaric therapy increases oxygen tension in tissues, supporting physiologic wound healing while inhibiting the growth of anaerobic organisms. Randomized clinical studies confirm that HBOT accelerates wound healing and decreases the need for amputation in patients with diabetic foot ulcers. Since oxygen has an important role in the physiology of wound healing, HBOT is a useful adjunct in the treatment of diabetic foot ulcers by helping to increase tissue oxygen tensions to levels that promote wound healing, limit edema (swelling caused by excess fluid trapped in your body’s tissues), and destroy certain anaerobic bacteria. Hyperbaric oxygen therapy is also a cost-effective modality. In 2003, Medicare and Medicaid extended coverage for hyperbaric oxygen therapy to ulcers that had failed standard wound care therapy and were classified as Wagner grade 3 or higher (a wound that is no longer superficial, but probes to bone and may be ischemic and/or infected).
Orlando Hyperbarics provides Hyperbaric Oxygen Therapy (HBOT) in a convenient and comfortable non-hospital facility. The center, located at 6200 Lee Vista Boulevard, Suite 250, Orlando, Florida 32822, is served by SR 436 and SR 528, easily accessed from Orlando International Airport, and located near Orlando’s Medical City in Lake Nona.